Fact CheckerSign in

NCT04763824Completed

KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice

Source: ClinicalTrials.gov · Last updated 14 Jan 2026

Brief summary (registry, in English)

Approximately, 20 rural primary care practices to participate in a delayed intervention-controlled trial. Phase I: Formal and structured work flow evaluations to better identify specific gaps in processes of care while assessing what on-going training is needed for adoption of high-quality cancer survivorship care in rural practice. These will be incorporated into the ECHO sessions (Aim 1). Phase II: Conduct and test the effectiveness of the novel KanSurvive-ECHO intervention (Aim 2) and finally identify barriers and facilitators to implementation of KanSurvive-ECHO (Aim 3).

Status (registry)
Completed
Study type
Interventional
Enrollment
15 (actual)
First submitted
25 Nov 2020
Start date
18 Nov 2020
Primary completion date
18 Dec 2023
Lead sponsor
University of Kansas Medical Center
NCT number
NCT04763824

What you commit to

  • Study type: Interventional
  • Participants enrolled: 15
  • From 18 Nov 2020 to the primary completion date, 18 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Cancer survivor data is ineligible for extraction if the patient is \<18 years of age or \>75 years of age, is currently receiving hospice services, or has a history of cancer other than breast, prostate, lung, or colorectal.

Other

  • PCPs unwilling to engage in project activities
  • PCPs with no rural-dwelling patients on their patient panel

Who the study is looking for

  • Primary care practice (PCP) caring for rural cancer survivors
  • Willing to participate in four ECHO sessions
  • Capable and willing to complete pre- and post- data collection under a data use agreement
  • Cancer survivor data is eligible for extraction if the patient is a breast, prostate, lung, and/or colorectal cancer survivor and considered to have a "reasonable likelihood" of 24-month survival by a practice provider.

Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Kansas Cancer Center
Coordinator of this site? Confirm its status
WestwoodUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.